ARTICLE | Company News
Neoprobe, AstraZeneca deal
December 19, 2011 8:00 AM UTC
AstraZeneca granted Neoprobe exclusive, worldwide rights to AZD4694, a late-stage radiopharmaceutical imaging agent that binds to beta amyloid deposits to detect Alzheimer's disease. AstraZeneca rec...